LP3 Network Free Webinar - Veterinary Compounding, A Customized Approach

Download in electronic PDF format for $25



Search the Complete Journal Archives

Compatibility of Paclitaxel Injection Diluent with Two Reduced-Phthalate Administration Sets for the Acclaim Pump

Author(s):  Xu Quanyun A, Trissel Lawrence A

Issue:  Sep/Oct 1998 - Parenteral Nutrition Solutions
View All Articles in Issue

Abstract:  The purpose of this project was to evaluate the compatibility of paclitaxel admixtures with the two reduced-phthalate administration sets designed for use with the Acclaim® Infusion Control Device. The first is a nitroglycerin set composed of polyethylene tubing, while the second is made using tris(2-ethylhexyl) trimellitate (TOTM)-plasticized polyvinyl chloride tubing. Both sets utilize a diethylhexyl phthalate (DEHP)- plasticized pumping segment. The potential for extraction of DEHP from the pumping segments and TOTM plasticizer from the plastic matrix by the Cremophor® EL surfactant present in the paclitaxel injection was evaluated.

Diethylhexyl phthalate and TOTM plasticizer extraction was tested using the paclitaxel diluent at concentrations equivalent to 0.3 and 1.2 mg/mL over three-hour and four-day infusions. All samples were prepared in triplicate in polyolefin bags of 5% dextrose injection and delivered through the administration sets into glass collection flasks. Both DEHP and TOTM content were determined using high-performance liquid chromatographic methods.

None of the admixtures delivered rapidly over three hours or slowly over four days through the TOTM-plasticized set exhibited any detectable TOTM. Similarly, no DEHP was detected in the effluent from either set with the simulated 0.3-mg/mL admixtures delivered over three hours. The simulated 1.2-mg/mL admixture delivered over three hours yielded only a barely detectable, but not quantifiable, trace of DEHP. However, slow delivery of both concentrations over four days through both sets resulted in leached DEHP in concentrations ranging from about 30 to 150 µg/mL at both one and four days.

The two reduced-phthalate administration sets tested in this study are suitable for the administration of paclitaxel infusions of short duration, for up to three hours. However, the sets cannot be recommended for administration over longerduration delivery times ranging from one to four days due to leaching of DEHP plasticizer from the pumping segments.

Related Keywords: cremaphor, diluent, hplc, paclitaxel, phthalate, taxol, trimellitate

Related Categories: CANCER AND AIDS, INFUSION, PEER-REVIEWED

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Compatibility of Paclitaxel Injection Diluent with Two Reduced-Phthalate Administration Sets for the Acclaim Pump Xu Quanyun A, Trissel Lawrence A Sep/Oct 1998 382-384 Buy
Extemporaneous Formulations: How to Evaluate HPLC Stability Studies Chan Debora Schotik Nov/Dec 1999 447 Buy
Capsule and Tablet Diluents, Featured Excipient: Allen Loyd V Jr Jul/Aug 2000 306 Buy
Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion Desai Narendra R, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A Sep/Oct 2007 426-432 Buy
Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration Zhang Yang, Scarlett Cameron, Hutson Paul Jan/Feb 2012 82-85 Buy
Paclitaxel 6-mg/mL Injection Allen Loyd V Jr Mar/Apr 2013 151 Buy
Compounding an Extended Stability Admixture of Paclitaxel for Long-Term Infusion Trissel Lawrence A, Xu Quanyun, Martinez Juan F Jan/Feb 1997 49-53 Buy
Paclitaxel Compatibility with IV Express Filter Unit Xu Quanyun A, Trissel Lawrence A, Zhang Yanping May/Jun 1998 243-245 Buy
Featured Excipient: Plasticizers Allen Loyd V Jr Mar/Apr 2003 145 Buy
Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting de Oliveira Ferreira Anderson, Holandino Carla Mar/Apr 2008 163-169 Buy